Neurotensin receptor agonists and antagonists for schizophrenia [13] (multiple letters)

American Journal of Psychiatry

Volumn 162, Issue 3, 2005, Pages 633-635

  Richelson, Elliott ^a   Fredrickson, Paul A ^a   Boules, Mona M ^a   Robertson, Vida B ^a   Wilson II, Michael S ^a   Meltzer, Herbert Y ^a   Arvanitis, Lisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CLOZAPINE; EPLIVANSERIN; HALOPERIDOL; MIRTAZAPINE; NEUROTENSIN; NEUROTENSIN RECEPTOR AGONIST; NEUROTENSIN RECEPTOR ANTAGONIST; NT 69L; OSANETANT; PEPTIDASE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; TRYPTOPHAN; UNCLASSIFIED DRUG;

AKATHISIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG RESEARCH; EXTRAPYRAMIDAL SYMPTOM; FISHER EXACT TEST; HUMAN; LETTER; NEGATIVE SYNDROME; NONHUMAN; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BLOOD-BRAIN BARRIER; CLINICAL TRIALS; DRUGS, INVESTIGATIONAL; HUMANS; NEUROTENSIN; PEPTIDE FRAGMENTS; PYRAZOLES; QUINOLINES; RECEPTORS, NEUROTENSIN; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 14844293528     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)